ロード中...
Prognostic impact of mutation profiling in patients with stage II and III colon cancer
Development of colorectal cancer (CRC) associates with accumulation of genetic mutations include the epidermal growth factor receptor (EGFR) signaling pathway. However, whether mutations in KRAS together with downstream factors BRAF, PIK3CA and NRAS impact prognosis is still unclear for stage II-III...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830995/ https://ncbi.nlm.nih.gov/pubmed/27074743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|